Axapharm

Axapharm is a Swiss pharmaceutical company headquartered in Baar that specializes in the marketing and distribution of high-quality generic medicines and specialized pharmaceutical products. Founded in 2003, the company has established a strong presence in the Swiss healthcare market by offering a broad portfolio of prescription and over-the-counter medications. Its product range covers various therapeutic areas, including pain management, cardiovascular health, dermatology, and central nervous system disorders. In early 2022, Axapharm was acquired by the German pharmaceutical group Dermapharm Holding SE, which has further strengthened its product pipeline and distribution capabilities. The company is dedicated to providing cost-effective healthcare solutions while maintaining high standards of quality and reliability for patients and healthcare professionals.